Abstract
CGS 22745, and aralkyl hydroxamic acid, inhibited 5-hydroxyeicosatetraenoic acid (5-HETE) and leukotriene B4 (LTB4) synthesis in guinea pig leukocytes (IC50=0.6μM). The compound did not appreciably affect cyclooxygenase (ram seminal vesicles), 12-lipoxygenase and thromboxane synthase (human platelets) or 15-lipoxygenase (human neutrophils). CGS 22745 inhibited A23187-induced formation of LTB4 in blood (IC50's of 4.3, 0.56 and 3.2 μM for human, dog and rat, respectively). At 1 mg/kg i.v. in dogs, it caused 96% inhibition of A23187-stimulated LTB4 formationex vivo after 5 min. Its effective biological half-life was >160 min. In dogs at 3 and 10 mg/kg p.o., CGS 22745 inhibitedex vivo A23187-stimulated LTB4 formation at 3 hr by 48% and 97%, respectively. The inhibition persisted up to 6 hr (26% at 3 mg/kg; 49% at 10 mg/kg). CGS 22745 (3, 10 and 30 mg/kg p.o.) inhibited exudate formation, mononuclear cells and PMN accumulation in a dose-dependent manner during the late phase (48 and 72 hr) of carrageenan-induced pleurisy in the rat.
Similar content being viewed by others
References
B. Samuelsson,Leukotrienes: Mediators of immediate hypersensitivity reactions and inflammation. Science220, 568–575 (1983).
G. A. Higgs,The effects of lipoxygenase inhibitors in anaphylaxis and inflammatory responses in vivo. Prostaglandins, Leukotrienes and Medicine13, 89–92 (1984).
R. Creticos, S. P. Peters, N. F. Adkinson, R. M. Naclerio, E. C. Hayes, P. S. Norman and L. M. Lichtenstein,Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N. Engl. J. Med310, 1626–1630 (1984).
Z. Chustecka,The script leukotriene report. PJP Publications Ltd. Surrey, U.K. (1985).
A. K. Black, R. D. R. Camp, A. I. Mallet, F. M. Cunningham, M. Hofbauer and M. W. Greaves,Pharmacologic and clinical effect of lonapalene (RS 43179), a 5-lipoxygenase inhibitor, in psoriasis. J. Invest. Dermatol.95(1), 50–54 (1990).
E. C. Ku, A. Raychaudhuri, G. Ghai, E. F. Kimble, W. H. Lee, C. Colombo, R. Dotson, T. D. Oglesby and J. W. F. Wasley,Characterization of CGS 8515 as a selective-5-lipoxygenase inhibitor using in vitro and in vivo models. Biochim. Biophys. Acta.959, 332–342 (1988).
A. P. Almeida, B. M. Bayer, Z. Horakova and M. A. Beaven,Influence of indomethacin and other anti-inflammatory drugs on mobilization and production of neutrophils: Studies with carrageenan-induced inflammation in rats. J. Pharmacol. Exp. Ther.214, 74–79 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kimble, E., Kowalski, T., White, D. et al. CGS 22745: A selective orally active inhibitor of 5-lipoxygenase. Agents and Actions 34, 125–128 (1991). https://doi.org/10.1007/BF01993256
Issue Date:
DOI: https://doi.org/10.1007/BF01993256